학술논문
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial
Document Type
Article
Author
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 March 2022, 28(6):1157-1166)
Subject
Language
English
ISSN
15573265
10780432
10780432